DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice
- 21 December 2004
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 23 (6), 819-826
- https://doi.org/10.1016/j.vaccine.2004.06.048
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sustained and Complete Phenotype Correction of Hemophilia B Mice Following Intramuscular Injection of AAV1 Serotype VectorsMolecular Therapy, 2001
- Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene TransferJournal of Virology, 2001
- A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency VirusHuman Gene Therapy, 2001
- Optimised helper virus-free production of high-quality adeno-associated virus vectorsThe Journal of Gene Medicine, 2000
- Induction of CTL response by a minimal epitope vaccine in HLA A∗0201/DR1 transgenic mice: dependence on HLA class II restricted TH responseHuman Immunology, 2000
- H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesEuropean Journal of Immunology, 1999
- Induction of Immunity to Antigens Expressed by Recombinant Adeno-Associated Virus Depends on the Route of AdministrationClinical Immunology, 1999
- Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral VectorsHuman Gene Therapy, 1998
- Dual-target Inhibition of HIV-1 in Vitro by Means of an Adeno-Associated Virus Antisense VectorScience, 1992
- The structure of the major immediate early gene of human cytomegalovirus strain AD169Virus Research, 1985